Clinical Trials

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

    Investigator: Bincy Abraham

    Study Coordinator:

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT01848561

    Phone:

    Protocol Number: Pro00011106

    Description


    This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.